KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Edwards Lifesciences (EW) over the last 15 years, with Q3 2025 value amounting to $586.2 million.

  • Edwards Lifesciences' Shares Outstanding (Weighted Average) fell 234.88% to $586.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $586.2 million, marking a year-over-year decrease of 234.88%. This contributed to the annual value of $597.7 million for FY2024, which is 148.34% down from last year.
  • Per Edwards Lifesciences' latest filing, its Shares Outstanding (Weighted Average) stood at $586.2 million for Q3 2025, which was down 234.88% from $587.0 million recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Shares Outstanding (Weighted Average) ranged from a high of $623.6 million in Q3 2021 and a low of $586.2 million during Q3 2025
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $607.2 million (2023), whereas its average is $608.8 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first grew by 20.89% in 2021, then tumbled by 250.79% in 2025.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Shares Outstanding (Weighted Average) stood at $623.3 million in 2021, then fell by 0.69% to $619.0 million in 2022, then dropped by 1.99% to $606.7 million in 2023, then decreased by 1.48% to $597.7 million in 2024, then decreased by 1.92% to $586.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $586.2 million for Q3 2025, versus $587.0 million for Q2 2025 and $586.9 million for Q1 2025.